What is Chugai Pharmaceutical Co., Ltd. (4519)?
Chugai Pharmaceutical Co., Ltd. is a Japanese biotechnology and pharmaceutical company specializing in the development and commercialization of prescription drugs. The company focuses on areas including oncology, immunology, and bone and joint diseases. Chugai engages in research and development activities to create innovative therapies, often collaborating with global partners. It operates manufacturing facilities and maintains a presence in international markets. The company's portfolio includes biologics and small molecule drugs designed to address complex medical conditions. Chugai Pharmaceutical contributes to the pharmaceutical industry through its emphasis on science-driven innovation and patient care.
Chugai Pharmaceutical Co., Ltd. Stock Price Today: Live Overview
The price today is shaped by the latest movements, with Chugai Pharmaceutical Co., Ltd. trading at ¥9166.1. It has fluctuated between ¥9004.7 and ¥9220.5, reflecting a daily change of -1.781%.
FAQ: Chugai Pharmaceutical Co., Ltd. (4519)
What is the current price of 4519 stock?
The current price is ¥9166.1.
Does 4519 pay dividends?
Chugai Pharmaceutical Co., Ltd. pays dividends via cash distributions (if applicable).
Does 4519 have a formal corporate presence or regional headquarters in the UAE?
Chugai Pharmaceutical Co., Ltd. operates through partners and distributors and does not have an official regional office in the UAE.
What is 4519 best known for?
Chugai Pharmaceutical Co., Ltd. is most famous for biopharmaceutical research and oncology products.
What assets are typically shown together with 4519?
Commonly shown alongside 4519: SPDR MSCI Europe Energy UCITS ETF, Gyre Therapeutics Inc, SIGA Tech
Latest shares articles



